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CathelicidinsCationic antimicrobial peptides (CAMPs) are important elements of innate immunity in higher organisms,
representing an ancient defense mechanism against pathogenic bacteria. These peptides exhibit broad-
spectrum antimicrobial activities, utilizing mechanisms that involve targeting bacterial membranes. Recently, a
34-residue CAMP (NA-CATH) was identiﬁed in cDNA from the venom gland of the Chinese cobra (Naja atra). A
semi-conserved 11-residue pattern observed in the NA-CATH sequence provided the basis for generating an
11-residue truncated peptide, ATRA-1A, and its corresponding D-peptide isomer. While the antimicrobial and
biophysical properties of the ATRA-1A stereoisomers have been investigated, their modes of action remain un-
clear.More broadly,mechanistic differences that can arisewhen investigatingminimal antimicrobial unitswithin
larger naturally occurring CAMPs have not been rigorously explored. Therefore, the studies reported here are
focused on this question and the interactions of full-length NA-CATH and the truncated ATRA-1A isomers with
bacterial membranes. The results of these studies indicate that in engineering the ATRA-1A isomers, the associ-
ated change in peptide length and charge dramatically impacts not only their antimicrobial effectiveness, but also
the mechanism of action they employ relative to that of the full-length parent peptide NA-CATH. These insights
are relevant to future efforts to develop shorter versions of larger naturally occurring CAMPs for potential thera-
peutic applications.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cationic antimicrobial peptides (CAMPs) are pervasive in nature and
represent an evolutionarily ancient mechanism for defending against
invading microorganisms. These peptides exhibit broad spectrum anti-
microbial effectiveness and are important elements of innate immunity,
which provide the ﬁrst line of defense against infection. Despite their
widespreaduse, they exhibit limited bacterial resistance [1]. These qual-
ities provide CAMPs an advantage over conventional therapeutics for
ﬁghting infections. Although CAMPs offer great potential as the basis
for a new class of antibiotics, many of the details of the mechanisms
by which they exert their antimicrobial effects remain unclear. Greater
understanding of the relationship between CAMP physico-chemical
properties and antimicrobial action is needed in order to realize their
therapeutic potential.nd Biochemistry, George Mason
USA. Tel.: +7039938302.
Environmental Health Sciences,CAMPs have been shown to interact with bacterial membranes and
inmany cases inducemembrane disruption [2]. However, these interac-
tions appear to be complex and the correlations between peptide
physico-chemical properties, membrane composition and modes of
action are poorly understood. CAMPs are usually amphipathic peptides
presenting discrete cationic and hydrophobic surfaces. The spatial
partitioning of these surfaces allows favorable electrostatic interaction
with negatively charged lipid head groups on the outer surface of bacte-
rialmembranes and insertion into the hydrophobic interior of the bilay-
er, leading ultimately to membrane disruption [3,4]. Widely accepted
membrane disruption mechanisms range from the “barrel-stave”
model to the “carpet model”. In the “barrel-stave”model, amphipathic
helical peptides insert into the bacterial membrane, forming peptide
lined structures with large central pores [2,5,6]. A similar proposed
model is the “toroidal pore”where amphipathic helical peptides insert
into the lipidmembrane and form less deﬁned transient supramolecular
pores [5–7]. In the “carpet model,” the peptides gather and concentrate
at themembrane surface, interactingwith the anionic lipid head groups,
until the peptide concentration threshold is reached. This results in
distortions in the lipid bilayer curvature and formation of transient
gaps in the membrane [2,5,6].
Fig. 1. Helical wheel projection* and peptide sequences with associated net charge. The helical wheel projections of NA-CATH (left) and ATRA-1A (right) display hydrophilic residues as
circles, hydrophobic residues as diamonds and positively charged residues as pentagons with the hydrophobic moment denoted in the center. Below the helical wheel projections are
tables containing peptide sequence, length and charge information. The ATRA motifs are shaded gray in the NA-CATH sequence with the residues that differ between the motifs
underlined. * Generated using http://rzlab.ucr.edu/scripts/wheel/wheel.cgi.
2 Commercial equipment and material suppliers are identiﬁed in this paper to ade-
quately describe experimental procedures. This does not imply endorsement by NIST.
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as evolutionary relationships, conserved sequence patterns and struc-
tural elements. Cathelicidins are a sequence diverse family of vertebrate
CAMPs that have been identiﬁed based on the highly conserved cathelin
domain present in the precursor protein [8–11]. Recently, the sequence
of a 34-residue helical cathelicidin, NA-CATH, was identiﬁed from cDNA
derived from the venom glands of the elapid snake, Naja atra [12,13].
Analysis of the NA-CATH sequence revealed a semi-conserved 11-
residue repeated sequence pattern. The 11-residue peptide amide,
ATRA-1A,was designed based on this pattern (Fig. 1) [14]. Furthermore,
the D-isomer of ATRA-1A was also investigated because D-peptide
isomers have been shown to be more resistant to proteases than the
corresponding L-peptides, which could enhance a peptide's therapeutic
utility [15–17]. Signiﬁcant disparities were observed in the antimicro-
bial effectiveness of the ATRA-1A stereoisomers [15]. Moreover, circular
dichroism studies noted subtle dissimilarities in the structural proper-
ties of thepeptide isomers in the presence ofmodel anionicmembranes,
and differences in their abilities to disrupt model membranes and in-
duce aggregation became evident in turbidity studies and ﬂuorescence
microscopy. While these studies focused on subtle differences in the
properties of the ATRA-1A peptide isomers and their interactions with
model membranes, they did not consider full-length NA-CATH, and
how its properties may compare to those of the shorter ATRA-1A
isomers.
The present study focuses on mechanistic differences that may arise
when studying full-length CAMPs and antimicrobially active truncated
versions of the peptide in order to identify minimal peptide units
retaining antimicrobial activity and regions of the larger peptides re-
sponsible for their antimicrobial activity. We have investigated the
full-length CAMP NA-CATH and the L- and D-isomers of the truncated
peptide ATRA-1A in order to explore how altering CAMP length can
affect antimicrobial activity and interaction with bacterial membranes.
Speciﬁcally, we aim to more clearly elucidate similarities and differ-
ences in the membrane disruption mechanisms employed by full-
length NA-CATH and the ATRA-1A isomers by focusing on key aspectsof peptide-induced membrane disruption and antimicrobial kinetics in
high and low salt environments against Escherichia coli and Bacillus
cereus.
2. Material and methods
2.1. Materials
The peptides used in these studies were custom synthesized by
AAPPTEC, LLC (Louisville, KY).2 The supplier reported purities of
NA-CATH, L-ATRA-1A and D-ATRA-1A were 95.0%, 95.2% and 95.4%,
respectively, based on high-performance liquid chromatography
(HPLC) analysis of the puriﬁed peptides. The bacterial strains of
Escherichia (E.) coli (ATCC# 25922) and Bacillus (B.) cereus (ATCC#
11778) used in these studies were purchased from the American Type
Culture Collection (Manassas, VA). 3,3′-dipropylthiacarbocyanine
(diSC3-(5)) was purchased from AnaSpec (Fremont, CA). SYTOX Green
was purchased from Invitrogen (Carlsbad, CA). Mueller Hinton Broth
(MHB) was purchased from Becton Dickinson and Company (Sparks,
MD). 4-(2-Hydroxyethyl)-1-piperazine ethane sulfonic acid (HEPES)
was purchased from Acros Organics (New Jersey, US). Phosphate buff-
ered saline (PBS) was purchased from Corning-cellgro (Manassas, VA).
Resazurin, sodium salt was purchased from Sigma-Aldrich (St. Louis,
MO). A SpectraMax Gemini EM was used for all experiments utilizing
a plate-reading ﬂuorimeter (Molecular Devices, Sunnyvale, CA).
2.2. Antimicrobial activity
The antimicrobial performances of NA-CATH, L-ATRA-1A and D-
ATRA-1Awere determined using a resazurin-based assay [18,19]. Frozen
enumerated bacterial aliquots were thawed on ice and gently mixed.
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buffer (10 mM phosphate buffer, pH 7.4) or high salt buffer (10 mM
phosphate buffer, 100 mM KCl, pH 7.4) and added in 50 μL aliquots to
the wells of a black 96-well microtiter plate containing serially diluted
peptide (50 μL) dissolved in the same buffer. In these assays control
wells were prepared containing bacteria with no peptide. The micro-
titer plate was incubated for 3 h at 37 ° C (E. coli) or 30 ° C (B. cereus).
After 3 h, 100 μL of PBS solution with dissolved resazurin and MHB
was added to thewells of themicrotiter plate. The amounts of resazurin
and MHB used were dependent on bacterial strain, with the ﬁnal
resazurin/MHB concentrations (w/v) being 100 μM resazurin/0.2%
for E. coli and 12.5 μM resazurin/0.05% for B. cereus. Following addition
of resazurin/MHB buffer, the plate was immediately placed in a plate-
reading ﬂuorimeter for incubation overnight at either 37 °C (E. coli)
or 30 °C (B. cereus) while monitoring ﬂuorescence for each well
(530 nmex/590 nmem). These antimicrobial measurements were per-
formed in triplicate in order to provide statistical signiﬁcance.
Fluorescence data for each well was compiled and the onset time of
half maximal ﬂuorescence (T0.5) was determined. For both E. coli and
B. cereus, standard curveswere generated using serially diluted bacterial
suspensions (~106 CFU/mL–103 CFU/mL) in the absence of CAMPs.
Observed T0.5 values were plotted against initial CFU counts, which
were veriﬁed by plating onMHB agar plates. Analysis of the data by lin-
ear regression produces the following Eq. (1) for E. coli and Eq. (2) for
B. cereus.
log CFU=mLE: colið Þ ¼ −0:0002 T0:5ð Þ þ 9:314 ð1Þ
log CFU=mLB: cereusð Þ ¼ −0:0002 T0:5ð Þ þ 6:475 ð2Þ
Eqs. (1) and (2)were then used to interpolate the surviving bacterial
concentration (CFU/mL) based on T0.5 values determined following in-
cubation with varied peptide concentrations. These values were used
to calculate bacterial survival (%) relative to cultures incubated in the
absence of peptide. The peptide concentration required to kill 50% of
the viable cells in the assay (EC50) was determined by plotting survival
as a function of the log of peptide concentration (logmg/mL) and ﬁtting
the data, usingGraphPad PrismX5 (Graph-Pad Software, SanDiego, CA)
to Eq. (3), which describes a sigmoidal dose–response curve.
Y ¼ Bottom þ Top−Bottomð Þ= 1 þ 10 logEC50 – Xð Þ ∗Hill Slope½ 
 
ð3Þ
2.3. Antimicrobial kinetics
The antimicrobial kinetics of NA-CATH, L-ATRA-1A and D-ATRA-1A
were evaluated in triplicate under both low (10 mM phosphate buffer,
pH 7.4) and high (10 mM phosphate buffer, 100 mM KCl, pH 7.4)
salt conditions at peptide concentrations of 200, 2 and 0.2 μg/mL
and time intervals of 0.5, 2, 4, 10 and 20 min. In a 96-well plate, 55 μL
of a 400 μg/mL peptide solution in buffer was added to 5 wells (1 well
for each time point) and then serially diluted by taking 5 μL of peptide
into 50 μL of buffer. Frozen aliquots of either E. coli or B. cereus were
thawed on ice and then diluted in buffer to a concentration of
1 × 105 CFU/mL. Using a multi-channel pipette, 50 μL of bacterial stock
was added to each well containing peptide solution. Additionally,
aliquots of bacterial stockwere added towells containing 50 μL of buffer
as a survival reference. The prepared plate was allowed to incubate at
room temperature with samples being collected at 0.5, 2, 4, 10 and
20 min. Samples collected for each time point were diluted 10-fold
by taking 50 μL from the 96-well plate into 450 μL of 1× PBS and then
serially diluted using the same buffer. The surviving bacteria were
plated in triplicate and incubated for 18 h at 37 ° C (E. coli) or 30 ° C
(B. cereus). The percentage of the bacterial killing relative to the control
was determined for each peptide concentration at each time point. The
percent killing for each peptide concentration was plotted as a function
of time.2.4. Membrane depolarization assay
Cytoplasmic membrane depolarization was determined using the
membrane potential-sensitive cyanine dye diSC3-(5). In this meth-
od, frozen aliquots of enumerated bacteria (E. coli or B. cereus)
were thawed on ice and washed 3 times with buffer (5 mM HEPES
with 20 mM glucose, pH 7.4). Following washing, the pelleted bacte-
ria were re-suspended in HEPES buffer (5 mMHEPES, pH 7.4, 20 mM
glucose) containing either, 10 or 100 mM KCl. A 96-well plate was
prepared where wells are charged with 360 μL of bacterial suspension
(2 × 107 CFU/mL) and 4.19 μL of diSC3-(5) (200 nM) for a total volume
of 364.19 μL. The bacteriawere incubated at room temperature and ﬂuo-
rescence wasmonitored (622 nmex/670 nmem) until diSC3-(5) maximal
uptake was obtained. Maximal diSC3-(5) uptake is indicated by a base-
line in ﬂuorescence due to self-quenching as the dye concentrates in
the cell membrane. Peptide (NA-CATH, L- or D-ATRA-1A) was added
at varied concentrations (200–2 μg/mL) in 20 μL aliquots and the ﬂuo-
rescence increase due to induced depolarization of the cytoplasmic
membrane was recorded. A negative control of bacteria and diSC3-
(5) was used as a background. As a positive control, complete collapse
of the membrane potential was attained with valinomycin (200–
2 μg/mL), a potassium ionophore. Measurements were performed in
triplicate for each condition and each peptide. The peptide-induced
ﬂuorescence was baseline subtracted for each peptide and the maximal
relative ﬂuorescence units (RFU) were plotted as a function of peptide
concentration.
2.5. SYTOX Green uptake assay
Induced membrane permeabilization caused by NA-CATH, L- or D-
ATRA-1 was monitored via the ﬂuorescence increase that occurs when
the cationic cyanine dye SYTOX Green intercalates DNA. SYTOX Green
is impermeant to living cells, yet can easily penetrate compromised
membranes [4,20–22]. In this method, frozen aliquots of enumerated
bacteria (E. coli or B. cereus) were thawed on ice and washed 3 times
with buffer (5 mM HEPES with 20 mM glucose, pH 7.4). Following the
ﬁnal wash, the bacteria were pelleted and then re-suspended in 1 mL
of HEPES buffer (5 mMHEPES with 20 mM glucose, pH 7.4) containing
either 10 or 100 mM KCl. Aliquots of re-suspended bacteria were
further diluted with their respective buffers to a concentration of
4 × 107 CFU/mL in 1 mL. The diluted cells were then charged with
1 μL of 5 mM SYTOX Green and incubated for 15 min in the dark at
room temperature. Following incubation, bacteria-SYTOX suspension
was added in 100 μL aliquots to the wells of a 96-well plate and the
ﬂuorescence of each well monitored in order to establish baseline
ﬂuorescence. After baseline ﬂuorescence collection, 100 μL aliquots of
peptide solutions, with concentrations ranging from 200 to 2 μg/mL,
were added to each well and the increase in SYTOX Green ﬂuorescence
was measured (485 nmex/520 nmem). As a negative control, ﬂuores-
cence data was collected for bacteria suspended in buffer containing
SYTOX Green in the absence of peptide. As a positive control, melittin
(200–2 μg/mL) was added to bacterial cells to achieve complete lysis
and maximum ﬂuorescence. Measurements were performed in tripli-
cate for each condition and each peptide. The peptide-induced ﬂuores-
cence was baseline subtracted for each peptide and the maximal
relative ﬂuorescence units (RFU) were plotted as a function of peptide
concentration.
2.6. Scanning electron microscopy
Enumerated frozen aliquots of either E. coli or B. cereuswere thawed
on ice and then diluted to a concentration of 2 × 108 CFU/mL using
10 mM phosphate buffer (pH 7.4). Stock solutions were prepared for
NA-CATH, L-ATRA-1A and D-ATRA-1A (100 μg/mL) in 10 mM phos-
phate buffer (pH 7.4). Bacterial suspension and peptide solutions
(50 μL each) were added to the wells of a 96-well plate giving a ﬁnal
Table 1
Antimicrobial performance of NA-CATH and ATRA-1A isomers under high and low salt conditions. Antimicrobial activity is expressed in terms of EC50 (μg/mL) valueswith corresponding
95% conﬁdence interval ranges for E. coli and B. cereus.
*Values were obtained using a plating assay and have been previously published [13].
Bacterium Antimicrobial activity (EC50, μg/mL)
NA-CATH L-ATRA-1A D-ATRA-1A
High salt 95% CI range Low salt 95% CI range High salt 95% CI range Low salt 95% CI range High salt 95% CI range Low salt 95% CI range
E. coli 0.024 0.015 to 0.040 0.023 0.022 to 0.025 ~9.7 Very wide 4.3* 4.0 to 4.6 ~7.1 Very wide 1.4* 1.1 to 1.5
B. cereus 0.60 0.49 to 0.72 0.35 0.33 to 0.40 N/A N/A 73* 65 to 82 4.3 3.8 to 4.9 2.3* 2.1 to 2.6
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tide concentration based on those used in the membrane disruption as-
says. Controls consisting of bacteria alone suspended in buffer, as well
as, peptide alone suspended in buffer were similarly prepared. Treated
cells were then incubated for 20 min at room temperature. Following
incubation, bacterial-peptide and control solutions were ﬁltered on to
a 0.22 μmmembrane ﬁlter that had been pretreated with 0.1% poly-L-
lysine in order to improve cell adhesion to the ﬁlter [23]. The retentates
on the membrane surface were ﬁxed for 2 h with 2.5% glutaraldehyde,
dehydrated with graded ethanol series and then critical point dried.
An 8 nm layer of Au/Pd alloy was sputtered on the samples to avoid
charging in the microscope. Samples were imaged in high resolution
mode with an upper detector using a Hitachi-47003 FESEM at an accel-
erating voltage of 10 keV.3. Results and discussion
3.1. Antimicrobial effectiveness and kinetics
Ionic strength in media has historically been shown to impact the
antimicrobial activity of CAMPs [24–27]. For many CAMPs, high salt
conditions impede their ability to kill bacteria, however the degree to
which the peptides are affected can vary signiﬁcantly. Here, the anti-
microbial properties and bactericidal kinetics of full-length NA-CATH
and the ATRA-1A isomers have been assessed against representative
Gram-negative and Gram-positive bacteria, E. coli and B. cereus, respec-
tively under low and high salt conditions.
In order to assess the degree to which salt conditions impact their
antimicrobial effectiveness, the performances of NA-CATH, L-ATRA-1A
and D-ATRA-1A were evaluated against E. coli and B. cereus under
both low (10 mM phosphate buffer, pH 7.4) and high (100 mM KCl in
10 mM phosphate buffer, pH 7.4) salt conditions. The results of these
assays indicate that the half-maximal effective concentration (EC50)
values for the peptides are dependent on both the nature of the bacteria
being tested and the salt conditions (Table 1). Against theGram-negative
bacterium, E. coli, the EC50 values in low salt for NA-CATH, L-ATRA-1A
and D-ATRA-1A were 0.023 μg/mL, 4.3 μg/mL and 1.4 μg/mL, respective-
ly. In high salt conditions NA-CATH had an EC50 of 0.024 μg/mL, while
L-ATRA-1A and D-ATRA-1A had EC50s of ~9.7 μg/mL and ~7.1 μg/mL,
respectively. When tested against B. cereus, a Gram-positive bacterium,
the EC50 values for low salt conditions were found to be 0.35 μg/mL,
73 μg/mL, and 2.3 μg/mL for NA-CATH, L-ATRA-1A and D-ATRA-1A, re-
spectively. In high salt conditions, the EC50 value found for NA-CATH
was 0.60 μg/mL and that of D-ATRA-1A was 4.3 μg/mL. L-ATRA-1A
was completely ineffective against B. cereus under these conditions.
In addition to antimicrobial potency, the rate with which the
peptides exerted their bactericidal effect was evaluated under both
low and high salt conditions (E. coli — Fig. 2 and B. cereus — Fig. 3).
Here, initial killing kinetics were established by monitoring bacterial
survival as a function of time for the ﬁrst 20min following introduction
of peptide to the bacterial culture. In these studies, three peptide3 Commercial equipment and material suppliers are identiﬁed in this paper to ade-
quately describe experimental procedures. This does not imply endorsement by NIST.concentrationswere evaluated based on the range of EC50values exhib-
ited by the ATRA-1A isomers against E. coli and B. cereus; a sub EC50
concentration (0.2 μg/mL), a concentration near EC50 (2 μg/mL) and a
supra EC50 concentration (200 μg/mL). Under low salt conditions, the
peptides exhibited differences in their antimicrobial kinetics against
both bacteria. At a concentration of 200 μg/mL, full-length NA-CATH
achieved complete killing in less than 30 s against both E. coli (Fig. 2A)
and B. cereus (Fig. 3A). After 20 min, NA-CATH displayed ~25% killing
at a peptide concentration of 2 μg/mL and ~5% killing at 0.2 μg/mL for
both E. coli (Fig. 2; B and C) and B. cereus (Fig. 3; B and C). Under the
same conditions, L-ATRA-1A exhibited ~100% killing against E. coli at
200 μg/mL, while presenting ~25% killing at 2 μg/mL and ~20% killing
at 0.2 μg/mL (Fig. 2; A–C) after 20 min. Against B. cereus, ~90% killing
was observed for L-ATRA-1A at 200 μg/mL after 20min,while ~20% kill-
ing was achieved at 2 μg/mL and ~10% killing at 0.2 μg/mL in the same
timeframe (Fig. 3; A–C). While, D-ATRA-1A exhibited 100% killing at
200 μg/mL, ~50% killing at 2 μg/mL and ~20% killing at 0.2 μg/mL
(Fig. 2; A–C) against E. coli after 20 min. Against B. cereus, D-ATRA-1A
exhibited 100% and ~50% killing after 20 min at peptide concentrations
of 200 μg/mL and 2 μg/mL, respectively (Fig. 3; A and B), however
diminished killing (~5%) occurred at 0.2 μg/mL (Fig. 3C).
Under high salt conditions, the peptides exhibited changes in their
killing kinetics against both E. coli (Fig. 2D–F) and B. cereus (Fig. 3D–
F). However, NA-CATH at a concentration of 200 μg/mL kills 100% of
bacteria within 30 s for both E. coli and B. cereus, which is consistent
with the kinetics observed under low salt conditions (Figs. 2D and
3D). At lower concentrations, NA-CATH demonstrated ~45% killing
after 20 min at a peptide concentration of 2 μg/mL and ~0% killing at
0.2 μg/mL of peptide for E. coli (Fig. 2E and F), and ~35% killing at
2 μg/mL of peptide and ~15% killing at 0.2 μg/mL for B. cereus (Fig. 3E
and F). The killing kinetics for L-ATRA-1A against both E. coli and
B. cereuswere signiﬁcantly reduced under high salt conditions relative
to the killing kinetics observed in low salt medium. Against E. coli, L-
ATRA-1A exhibited ~25%, ~20%, and ~10% killing after 20min at peptide
concentrations of 200 μg/mL, 2 μg/mL and 0.2 μg/mL, respectively
(Fig. 2D–F). After 20 min incubation with B. cereus, L-ATRA-1A showed
killing of ~25% at 200 μg/mL of peptide, ~15% at 2 μg/mL and ~0% at
0.2 μg/mL (Fig. 3D–F). Against E. coli, D-ATRA-1A exhibited slower kill-
ing kinetics in high salt relative to that observed in low salt conditions.
Incubation of D-ATRA-1A with E. coli for 20 min resulted in killing of
~25%, ~25% and ~0% at peptide concentrations of 200 μg/mL, 2 μg/mL
and 0.2 μg/mL, respectively (Fig. 2D–F). Against B. cereus, D-ATRA-1A
showed ~25% killing at concentrations of 200 μg/mL and 2 μg/mL,
while at 0.2 μg/mL exhibited ~10% killing (Fig. 3D–F). From this data it
is clear that the salt conditions impact the killing kinetics of NA-CATH
and the ATRA-1A isomers, however the extent of the effect appears to
vary depending on the peptide and the bacterial strain.
The kinetics of antibacterial effectiveness, illustrated in Figs. 2 and 3,
have been observed for only the initial 20 min following addition of
peptide. The data indicates that NA-CATH's mechanism of action, at
peptide concentrations near the EC50, requires incubation for longer
than 20 min in order to exert its full bactericidal effectiveness. Against
E. coli, NA-CATHwas unable to achieve 50% killing at peptide concentra-
tions of 0.2 and 2 μg/mL within the 20 minute window, which are 10
and 100 times its EC50 determined in both low and high salt conditions
Fig. 2.Antimicrobial kinetics of NA-CATH and the ATRA-1A isomers against E. coli. The killing kinetics of NA-CATH (red), L-ATRA-1A (green) and D-ATRA-1A (blue)were evaluated against
E. coli in low salt conditions and high salt conditions at peptide concentrations of 200 μg/mL (A and D), 2 μg/mL (B and E) and 0.2 μg/mL (C and F). The data are reported as the average of
n = 3 and the 95% conﬁdence interval (CI) is indicated where appropriate.
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ited by NA-CATH against the Gram-positive bacterium B. cereus, where
half-maximal effectiveness was not achieved within the 20 minute
time frame at a peptide concentration of 2 μg/mL, which is ~6 times
the EC50 in low salt conditions (0.35 μg/mL) and ~ 3 times the EC50
value in high salt (0.60 μg/mL). Interestingly, at a supra EC50 peptide
concentration of 200 μg/mL, NA-CATH was able to completely kill 100%
of both bacterial strains within 30 s regardless of salt conditions.
The killing kinetics of L-ATRA-1A against E. coli under low-salt condi-
tions showed a quarter of the population surviving after 20min of incu-
bationwith 2 μg/mLof peptide,which is half the EC50 value (4.3 μg/mL).
While at a peptide concentration of 200 μg/mL (~46 times its EC50
value), L-ATRA-1A achieved nearly 100% killing after 20 min. In high
salt conditions, L-ATRA-1A failed to attain 50% killing against E. coli
within the 20 minute window even at a peptide concentration of
200 μg/mL, which is 20 times its EC50 (9.7 μg/mL). In low salt condi-
tions, L-ATRA-1A only reaches above 50% killing of B. cereus in the
same time period at a peptide concentration of 200 μg/mL, which
is ~3 times its EC50 value (73 μg/mL). This peptide exhibited limited
killing against B. cereus in high salt conditions, even at a peptide con-
centration of 200 μg/mL, which is consistent with the lack of killing
observed in the antimicrobial assays performed under similar condi-
tions (no measurable EC50). In contrast, the killing kinetics of D-
ATRA-1A showed 50% killing against E. coli at a peptide concentration
of 2 μg/mL under low salt conditions within 20 min, which is similar
to the peptides EC50 in the same conditions (1.4 μg/mL). Completekilling was obtained at a D-ATRA-1A concentration of 200 μg/mL for
E. coli in low salt conditions. Against B. cereus, D-ATRA-1A exhibited
similar results in low salt conditions with 50% killing being achieved
at a peptide concentration of 2 μg/mL, which is approximately equal to
its EC50 value of 2.3 μg/mL. As was the case with E. coli, 100% killing
was obtained against B. cereus using D-ATRA-1A at a peptide concentra-
tion of 200 μg/mL under low salt conditions. While the D-peptide failed
to attain 50% killing against either bacterial strain in high salt conditions
in the observed 20 minute window, even at a peptide concentration of
200 μg/mL, which is 28 times its EC50 against E. coli (7.1 μg/mL) and
50 times its EC50 against B. cereus (4.3 μg/mL).
The observed decreases in killing activity for the peptides in high salt
conditions are likely the result of multiple contributing factors. Direct
interaction of salt ions with the peptide's hydrophilic residues and the
lipid-bilayer head groups shields their respective charges and reduces
the electrostatic interactions [26]. Additionally, the high levels of activ-
ity observed for the peptides under low salt (0 KCl) conditions may
reﬂect increased bacterial susceptibility to membrane disruption and
lysis in such hypotonic environments [28]. Hofmeister effects, ionic
screening and speciﬁc ion binding between the solution ions and both
peptide side-chains and lipid head groups all likely contribute to the ob-
served reductions in antimicrobial effectiveness [29–32]. For example,
these interactions could result in a reduction in CAMP helicity, and
thus amphipathic character, which would greatly affect their ability to
directly interact with bacterial membranes and reduce or negate their
antimicrobial effectiveness.
Fig. 3. Antimicrobial kinetics of NA-CATH and the ATRA-1A isomers against B. cereus. The killing kinetics of NA-CATH (red), L-ATRA-1A (green) and D-ATRA-1A (blue) were evaluated
against B. cereus in low salt conditions and high salt conditions at peptide concentrations of 200 μg/mL (A and D), 2 μg/mL (B and E) and 0.2 μg/mL (C and F). The data are reported as
the average of n = 3 and the 95% conﬁdence interval (CI) is indicated where appropriate.
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Cationic antimicrobial peptides in general have been shown to be
capable of causing varying degrees of disruption in bacterial mem-
branes, ranging from transient gaps, to large pores and micellization.
Accordingly, the extent towhichNA-CATHand the ATRA-1A isomers in-
teract with bacterial membranes was ascertained using assays designed
tomonitormembrane depolarization and permeabilization over a range
of peptide concentrations (2, 12.5, 25, 50, 100 and 200 μg/mL). Depolar-
ization of bacterial membranes was evaluated using diSC3-(5), a mem-
brane potential sensitive dye, which concentrates within the lipid
bilayer resulting in the dye self-quenching [4,22,27,33,34]. If peptides
depolarize the membrane, the potential dissipates, and diSC3-(5) is
released into solution causing an increase in ﬂuorescence, which is
directly proportional to the degree of membrane potential reduction.
Uptake of SYTOX Green, a nucleic acid stain, was used to detect greater
degrees of peptide-induced membrane permeabilization. SYTOX Green
is impermeant to the membranes of healthy cells, but can penetrate
disrupted cell membranes and bind to nucleic acids [21]. If the bacterial
cell membrane integrity is compromised by pores large enough to
allow passage or cell lysis, inﬂux of the dye and subsequent binding to
DNA causes a N500-fold increase in ﬂuorescence [4,20–22]. Scanning
electron microscopy (SEM) allows for visualization of morphological
changes in bacterial membranes [20,35–37]. Therefore, SEM was used
to probe the ability of the CAMPs to induce gross changes in membranemorphology, including blebbing, aggregation, pore formation and cell
lysis.
The results of the diSC3-(5) depolarization studies indicate that all
three peptides differentially dissipate membrane potential in E. coli
and B. cereus to varying degrees, depending on peptide concentration
and salt conditions. In low salt conditions, NA-CATH was able to depo-
larize both E. coli (Fig. 4A) and B. cereus (Fig. 4B) cells at 2 μg/mL, the
lowest peptide concentration tested, with depolarization increasing
as the peptide concentration increased. Under high salt conditions,
NA-CATH induced depolarization was not detected against E. coli cells
at peptide concentrations below 100 μg/mL, with depolarization at
100 and 200 μg/mL being considerably lower than those seen in low
salt conditions (Fig. 4C). In contrast, NA-CATH caused depolarization
of B. cereus cells at a peptide concentration of 2 μg/mL under high salt
conditions, with depolarization increasing as the peptide concentration
increased up to 100 μg/mL (Fig. 4D). However, increasing the peptide
concentration from 100 μg/mL to 200 μg/mL resulted in no signiﬁcant
change in depolarization. Under low salt conditions, both L- and D-
ATRA-1A exhibited depolarization of E. coli cells at peptide concentra-
tions as low as 2 μg/mL, with increased depolarization occurring at
higher peptide concentrations (Fig. 4A). On the other hand, the ATRA-
1A isomers only produced slight depolarization of B. cereus at peptide
concentrations ranging from 12.5 μg/mL to 200 μg/mL (Fig. 4B). In
high salt conditions, L-ATRA-1A exhibited no depolarization against
E. coli (Fig. 4C) and very little depolarization against B. cereus, even at
Fig. 4. Effect of peptide concentration onmembrane depolarization. Using diSC3-(5) ﬂuorescence tomonitor the effect of peptide concentration on induced membrane depolarization for
NA-CATH (▲), L-ATRA-1A (●) andD-ATRA-1A (■) in low salt conditions against E. coli (A) and B. cereus (B) and high salt conditionsE. coli (C) and B. cereus (D). The data are reported as the
average of n = 3 and the standard deviation is indicated by the error bars.
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of E. coli with D-ATRA-1A in high salt conditions did not afford signiﬁ-
cant depolarization (Fig. 4C). However, D-ATRA-1A induced slightly
greater depolarization against B. cereus than was achieved using L-
ATRA-1A (Fig. 4D).
From these results, it is evident that all three peptides exhibited
higher degrees of depolarization in a low salt environment than under
high salt conditions. In low salt conditions, L-ATRA-1A and D-ATRA-1A
displayed higher degrees of depolarization with E. coli than with
B. cereus, while NA-CATH showed similar depolarization with both
bacterial strains. Under high salt conditions, all three peptides showed
depolarization of B. cereus, while only NA-CATH exhibited any signiﬁ-
cant depolarization with E. coli. Membrane depolarization data for the
three peptides is consistent with their antimicrobial effectiveness and
killing kinetics.
To further investigate the extent of membrane disruption induced
by NA-CATH and the ATRA-1A isomers, SYTOX Green ﬂuorescence
was used as a reporter to assess membrane permeabilization and the
formation of larger pores and openings in bacterial membranes. In
these studies, none of the peptides exhibited signiﬁcantmembrane per-
meabilization against E. coli under either low or high salt conditions
(Fig. 5A and C). However, NA-CATHwas able to permeabilize themem-
branes of B. cereus under both salt conditions at peptide concentrations
as low as 25 μg/mL (Fig. 5B and D). Neither L-ATRA-1A nor D-ATRA-1A
was able to permeabilize the membranes of B. cereus in either low or
high salt conditions (Fig. 5A–D).
In the SYTOX Green uptake studies, NA-CATH induced membrane
disruption in Gram-positive bacterium B. cereus in both high and low
salt environments, which is consistent with the peptide's performance
in diSC3-(5) depolarization studies. Against the Gram-negative bacteri-
um E. coli, NA-CATH was unable to permeabilize the bacterial mem-
brane in either high or low salt conditions. This is in contrast to the
performance of NA-CATH in diSC3-(5) assays, where the peptide was
able to induce membrane depolarization in E. coli under low salt condi-
tions. In the cases of L-ATRA-1A andD-ATRA-1A, no SYTOXﬂuorescencewas displayed, even under low salt conditions where these peptides
exhibited signiﬁcant depolarization.
Greater understanding of the ability of CAMPs to inﬂict gross chang-
es in bacterial membranes can be achieved using SEM to visualize
morphological changes in bacteria that have been treated with either
NA-CATH or one of the ATRA-1A isomers. The exposure of E. coli
and B. cereus to 50 μg/mL of peptide for 20 min resulted in notable
alterations in cell morphology. When untreated E. coli cells were pre-
pared from low ionic strength buffer, the SEM images showed intact
cells with a corrugated morphology, typical of this strain (Fig. 6I; A
and B) [35]. However, E. coli exposed to peptide presented multiple
structural abnormalities. After incubation with L-ATRA-1A, the appear-
ance of the E. coli cells changed drastically, displaying blebbing on the
cell surfacewith some exhibiting cellular leakage (Fig. 6I; C andD). Sim-
ilar alterations were seen in E. coli treated with D-ATRA-1A, however
the extent of surface blebbing was signiﬁcantly greater (Fig. 6I; E and
F). E. coli exposed to NA-CATH exhibited large blebs along their surface,
cellular leakage, aswell as cell lysis (Fig. 6I; G andH). Untreated B. cereus
prepared from low ionic strength buffer in the absence of peptide
appeared normal, exhibiting smooth cell membranes and minimal
aggregation (Fig. 7I, A and B). Minor morphological changes were ob-
served in B. cereus exposed to L-ATRA-1A, which displayed roughening
of the cell surface and micro-blebbing. Additionally, these cells exhibit
increased regions of cellular aggregation (Fig. 7I; C and D). Treatment
of B. cereus with D-ATRA-1A resulted in aggregation throughout the
entire sample, as well as, membrane roughening and micro-blebbing
(Fig. 7I; E and F). B. cereus cells treated with NA-CATH exhibited the
highest degree of aggregation, along with membrane blebbing, cellular
leakage, and large pore formation leading to cell lysis (Fig. 7I; G and H).
Under high salt conditions, the peptide-induced morphological
alterations in both E. coli (Fig. 6 II) and B. cereus (Fig. 7 II) were muted
relative to those produced in low salt conditions. When untreated
E. coli were prepared from high ionic strength buffer, the SEM images
showed intact cells with smoother surfaces than were seen in cells
from low salt buffer (Fig. 6II; A and B). Incubation of E. coliwith either
Fig. 6. SEMmicrographs of E. coli following peptide exposure. I. E. coli untreated under low-salt conditions (A and B), and following incubation with L-ATRA-1A (C and D), D-ATRA-1A
(E and F) and NA-CATH (G and H). In I A–H the scale bar is equal to 1 μm. II. E. coli untreated under high-salt conditions (A and B), and following incubation with L-ATRA-1A
(C and D), D-ATRA-1A (E and F) and NA-CATH (G and H). In II A–H the scale bar is equal to 1 μm. While the selected images illustrate morphological changes observed in the samples,
they do not reﬂect the distribution of these changes in the sample population.
Fig. 5. Effect of peptide concentration on membrane permeabilization. Evaluation of peptide-induced membrane permeabilization based on SYTOX Green ﬂuorescence using varied
concentrations of NA-CATH (▲), L-ATRA-1A (●) and D-ATRA-1A (■) in low salt conditions against E. coli (A) and B. cereus (B) and high salt conditions E. coli (C) and B. cereus (D). The
data are reported as the average of n = 3 and the standard deviation is indicated by the error bars.
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Fig. 7. SEMmicrographs of B. cereus following peptide exposure. I.B. cereusuntreated under low-salt conditions (A and B), and following incubationwith L-ATRA-1A (C andD), D-ATRA-1A
(E and F) and NA-CATH (G and H). In I the scale bar is equal to 50 μm (A, C, E, and G), 2 μm (B) and 1 μm (D, F, and H). II. B. cereus untreated under high-salt conditions (A and B), and
following incubation with L-ATRA-1A (C and D), D-ATRA-1A (E and F) and NA-CATH (G and H). In II the scale bar is equal to 50 μm (A, C, E, and G) and 2 μm (B, D, F, and H). While
the selected images illustrate morphological changes observed in the samples, they do not reﬂect the distribution of these changes in the sample population.
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surface roughening andmembrane blebbing, however the level of bleb-
bing was lower than that observed in similarly treated cells in low salt
conditions (Fig. 6II; C, D, E and F). In high salt conditions, E. coli exposed
to NA-CATH still exhibited substantial blebbing along their surface,
cellular leakage, and cell lysis (Fig. 6II; G and H). Untreated B. cereus
prepared in high salt displayed smooth cell morphology and increased
aggregation relative to that seen in cells from low salt buffer (Fig. 7II,
A and B). No changes in membrane morphology were observed in
B. cereus exposed to L-ATRA-1A or D-ATRA-1A, however these cells
did exhibit increased aggregation (Fig. 7II; C, D, E and F). Treatment of
B. cereus with NA-CATH under high salt conditions resulted in cellular
aggregation, as well as, roughening and micro-blebbing along the cell
surface and incidences of cell lysis (Fig. 7II; G and H).
While the selected images illustrate the morphological changes that
NA-CATH and the ATRA-1A isomers can inﬂict on bacterial membranes,
scanning the entire sample provided a clearer impression of the distri-
bution and extent of these changes within the bulk population. For
both E. coli and B. cereus, the morphological changes caused by NA-
CATH, in both low and high salt conditions, were more severe than
those seen with either of the ATRA-1A isomers. The ATRA-1A isomers
appeared to have a uniformeffect across the entire bacterial populations
for both E. coli and B. cereus. However, NA-CATH was less consistent in
its affect, with some cellsmanifesting severe detrimentalmorphological
changes and others appearing less affected. At 13.6mm× 35–20 kmag-
niﬁcation, 2 out of 5 E. coli cells and 2 out of 6 B. cereus cells treatedwith
NA-CATHunder low salt conditions exhibited visible damage to the bac-
terialmembrane.While under high salt conditions, 1 out of 5 E. coli cells
and 1 out of 7 B. cereus cells treatedwithNA-CATHdemonstrated visible
bacterial membrane damage at the same magniﬁcation.
The results of the membrane perturbation experiments employ-
ing diSC3-(5) and SYTOX Green reﬂect bulk properties and do notdistinguish the effect the peptides have on individual cells. By contrast,
SEM allows examination of individual cells within the population, thus
providing essential insights into the way that these peptides interact
with membranes and the antimicrobial mechanisms that they employ.
When the performance of NA-CATH and the ATRA-1A isomers in spec-
trophotometric assays is considered in conjunction with analysis of
their respective SEM images, patterns begin to emerge suggesting
both similarities and differences in the interactions of the peptides
with bacterial membranes (Table 2). While L-ATRA-1A showed signiﬁ-
cant depolarization for E. coli in low salt conditions and moderate
depolarization of B. cereus in both low and high salt environments, it
did not exhibit permeabilization for either bacterial strain in SYTOX
Green-based assays regardless of salt conditions. The SEM data for
cells treated with L-ATRA-1A showed mainly roughening and blebbing
of the cell membranes, suggesting that these membrane morphological
changes are not indicative of permeabilization. Similarly, the spectro-
photometric experiments showed that D-ATRA-1A produced strong
depolarization of E. coli in low salt buffer and moderate depolarization
of B. cereus in both low and high salt conditions, but failed to induce
permeabilization in either bacterial strain under both salt conditions.
However, SEM revealed that D-ATRA-1A produced a greater degree of
blebbing than was observed in cells treated with L-ATRA-1A. While
NA-CATH exhibited strong depolarization of E. coli and B. cereus and sig-
niﬁcant permeabilization of only B. cereus in the diSC3-(5) and SYTOX
Green assays, the SEM data revealed that the peptide had a more dra-
matic but less consistent impact on the cell morphology of both bacte-
rial strains than was seen with the shorter ATRA-1A isomers. Despite
their demonstrated ability to disrupt bacterial membrane integrity,
none of the peptides exhibit signiﬁcant hemolytic activity (see Supple-
mental material). This is signiﬁcant because hemolytic assays are
frequently used to evaluate the propensity of CAMPs to attack host
cell membranes.
Table 2
Qualitative comparison of spectrophotometric assay results and SEM image analysis. The results from diSC3-(5) and SYTOX Green assays and analysis of scanning electron microscopy
images for E. coli (A) and B. cereus (B) treatedwith NA-CATH and theATRA-1A isomers are illustrated in order tomore effectively capture the difference in the performance of the peptides.
Boxes shaded in white correspond to negative or slight response (−), light gray corresponds to a positive response (+) and dark gray corresponds to a strong positive response (++).
A
B
Peptide
E. coli
Spectrophotometric analysis Scanning electron microscopy image analysis
Depolarization Permeabilization Aggregation Blebbing Lysis
High salt Low salt High salt Low salt High salt Low salt High salt Low salt High salt Low salt
L–ATRA–1A – ++ – – – – + + – +
D–ATRA–1A – ++ – – – – + ++ – +
NA–CATH + ++ – – – – ++ ++ + ++
Peptide
B. Cereus
Spectrophotometric analysis Scanning electron microscopy image analysis
Depolarization Permeabilization Aggregation Blebbing Lysis
High salt Low salt High salt Low salt High salt Low salt High salt Low salt High salt Low salt
L–ATRA–1A + + – – ++ ++ – + – –
D–ATRA–1A + + – – ++ ++ – + – –
NA–CATH ++ ++ ++ + ++ ++ + ++ + +
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While detailedmechanisms of action for NA-CATH and the ATRA-1A
peptides cannot be extracted solely from the data reported here, this
research does provide insights into the potential avenues by which
these peptides exert their antimicrobial effects and suggests that signif-
icant differences exist in the ways that each peptide interacts with bac-
terialmembranes. In these studies, NA-CATH exhibits very high potency
in both high and low salt environments and the ability to rapidly cause
bacterial membrane disruption at low peptide concentrations. In the
cases of the shorter ATRA-1A isomers, D-ATRA-1A appears to be more
potent than its L-counterpart, however the data presented here sug-
gests that the nature of their interactions with bacterial membranes is
similar. SEM images for bacteria incubated with full-length NA-CATH
reveal an uneven ﬁeld of cell destruction, with some cells being
completely lysed while others appear unaffected. In contrast, images
for the ATRA-1A isomers exhibit more uniform but more modest dis-
ruption of bacterial membrane surfaces. These results are consistent
with our earlier observation that exposure to high concentrations NA-
CATH resulted in the complete lysis of anionic liposomes, while incuba-
tion with the ATRA-1A peptides appeared to cause liposome leakage,
fusion and aggregation [15]. The current studies suggest NA-CATH and
the ATRA-1A peptide isomers employ different mechanisms of action.
The performance data and SEM images for NA-CATH appear to be con-
sistent with membrane disruption mechanisms that involve a degree
of cooperativity. The disruption mechanisms employed by the ATRA-
1A isomers seem to be less cooperative, possibly involving modes of
action resembling a carpet model. The differences observed in the be-
haviors of the full-length parent peptide, NA-CATH, and the truncated
ATRA-1A isomers demonstrate how altering the length and charge of
an antimicrobial peptide can impact not only their antimicrobial effec-
tiveness, but can also dramatically affect the mechanism of action that
they employ. Such mechanistic factors must be considered in future
efforts to identify minimal antimicrobial units within larger naturally
occurring peptides as the antimicrobial mechanisms that they employ
may differ signiﬁcantly from that of the parent peptide.Conﬂict of interest statement
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